Collective Family Office’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,017
Closed -$463K 171
2022
Q2
$463K Buy
6,017
+49
+0.8% +$3.73K 0.2% 114
2022
Q1
$436K Sell
5,968
-36
-0.6% -$2.42K 0.17% 130
2021
Q4
$374K Sell
6,004
-529
-8% -$31K 0.15% 132
2021
Q3
$387K Sell
6,533
-205
-3% -$13.5K 0.17% 125
2021
Q2
$450K Hold
6,738
0.19% 115
2021
Q1
$425K Buy
6,738
+650
+11% +$40.4K 0.21% 116
2020
Q4
$378K Buy
+6,088
New +$374K 0.21% 116

Other funds holding BMY

Collective Family Office's BMY Position: Q3 2022 in Review

Collective Family Office sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 6,017 shares — an estimated $463K sold.

Collective Family Office first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $463K in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Collective Family Office reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Collective Family Office sold 6,017 Bristol-Myers Squibb shares in Q3 2022, an estimated $463K.
  • Collective Family Office first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
  • Collective Family Office's Bristol-Myers Squibb position peaked at $463K in Q2 2022.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Collective Family Office's 13F filing for Q3 2022, filed 14 Oct 2022.